WAY | Waystar Holding Corp. Annual & Quarterly Balance

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021
Total Assets	4.72 Billion	4.81 Billion	4.89 Billion
Total Current Assets	216.55 Million	213.89 Million	163.98 Million
Cash And Short Term Investments	45.42 Million	72.63 Million	54.5 Million
Cash and Cash Equivalents	45.42 Million	72.63 Million	54.5 Million
Short Term Investments	23.35 Million	-	-
Net Receivables	132.9 Million	111.43 Million	103 Million
Inventory	-	-	-
Other Current Assets	38.22 Million	29.83 Million	6.47 Million
Total Non-Current Assets	4.51 Billion	4.59 Billion	4.72 Billion
Net PPE	71.61 Million	67.57 Million	58.63 Million
Good Will And Intangible Assets	4.21 Billion	4.33 Billion	4.5 Billion
Good Will	3.03 Billion	3 Billion	3 Billion
Intangible Assets	1.18 Billion	1.32 Billion	1.49 Billion
Long-Term Investments	-1000.00	15.64 Million	6.65 Million
Tax Assets	146.46 Million	115.91 Million	116.68 Million
Other Non Current Assets	77.86 Million	61.17 Million	43.62 Million
Other Assets	-	-	1.00
Total Liabilities	2.67 Billion	2.7 Billion	2.77 Billion
Total Current Liabilities	123.48 Million	102.21 Million	110.26 Million
Account Payables	45.48 Million	28.09 Million	34.82 Million
Tax Payables	3.5 Million	2.33 Million	3.27 Million
Short Term Debt	23.2 Million	22.75 Million	18.68 Million
Deferred Revenue	10.93 Million	9.9 Million	11.7 Million
Other Current Liabilities	43.86 Million	41.45 Million	45.04 Million
Total Non Current Liabilities	2.55 Billion	2.6 Billion	2.66 Billion
Long-Term Debt	2.19 Billion	2.2 Billion	2.26 Billion
Deferred Revenue Non Current	6.17 Million	6.55 Million	6.07 Million
Deferred Tax Liabilities Non Current	-	-	-
Other Non Current Liabilities	29.22 Million	30.72 Million	18.58 Million
Other Liabilities	-	-	-
Total Equity	2.04 Billion	2.1 Billion	2.12 Billion
Stock Holders Equity	2.04 Billion	2.1 Billion	2.12 Billion
Common Stock	1.21 Million	2.01 Million	2.01 Million
Retained Earnings	-201.77 Million	-150.44 Million	-98.98 Million
Accumulated other comprehensive income	15.8 Million	29.83 Million	-489 Thousand
Common Stock Equity	2.04 Billion	2.1 Billion	2.12 Billion
Capital Lease Obligation	26.47 Million	30.72 Million	13.76 Million
Total Investments	-1000.00	15.64 Million	6.65 Million
Total Debt	2.24 Billion	2.26 Billion	2.29 Billion
Net Debt	2.2 Billion	2.18 Billion	2.24 Billion

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	4.56 Billion	4.57 Billion	4.72 Billion	4.72 Billion	4.6 Billion	4.65 Billion
Total Current Assets	270.75 Million	250.48 Million	216.55 Million	216.55 Million	220.46 Million	257.02 Million
Cash And Short Term Investments	80.45 Million	70.8 Million	45.42 Million	45.42 Million	52.85 Million	104.94 Million
Cash and Cash Equivalents	80.45 Million	70.8 Million	45.42 Million	45.42 Million	52.85 Million	104.94 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	159.14 Million	135.8 Million	132.9 Million	132.9 Million	117.52 Million	106.37 Million
Inventory	-	-	-	-	-	-
Other Current Assets	31.14 Million	43.86 Million	38.22 Million	38.22 Million	50.08 Million	45.7 Million
Total Non-Current Assets	4.29 Billion	4.32 Billion	4.51 Billion	4.51 Billion	4.38 Billion	4.39 Billion
Net PPE	72.61 Million	71.16 Million	71.61 Million	71.61 Million	71.07 Million	70.36 Million
Good Will And Intangible Assets	4.13 Billion	4.17 Billion	4.21 Billion	3.03 Billion	3.02 Billion	4.25 Billion
Good Will	3.03 Billion	3.03 Billion	3.03 Billion	3.03 Billion	3.02 Billion	3 Billion
Intangible Assets	1.1 Billion	1.14 Billion	1.18 Billion	-	-	1.24 Billion
Long-Term Investments	-	681 Thousand	-1000.00	1.18 Billion	4.72 Million	7.95 Million
Tax Assets	-	-1000.00	146.46 Million	146.46 Million	1.22 Billion	-
Other Non Current Assets	84.72 Million	76.79 Million	77.86 Million	77.86 Million	67.26 Million	64.5 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	1.62 Billion	2.54 Billion	2.67 Billion	2.67 Billion	2.52 Billion	2.55 Billion
Total Current Liabilities	125.86 Million	132.02 Million	123.48 Million	123.48 Million	104.85 Million	111.69 Million
Account Payables	50.74 Million	42.76 Million	45.48 Million	45.48 Million	33.35 Million	36.16 Million
Tax Payables	4.03 Million	10.66 Million	3.5 Million	-	-	11.49 Million
Short Term Debt	18.48 Million	27.2 Million	23.2 Million	23.2 Million	23.3 Million	23.32 Million
Deferred Revenue	10.32 Million	12.7 Million	10.93 Million	10.93 Million	10.62 Million	9.72 Million
Other Current Liabilities	46.31 Million	49.34 Million	43.86 Million	43.86 Million	37.56 Million	42.47 Million
Total Non Current Liabilities	1.49 Billion	2.4 Billion	2.55 Billion	2.55 Billion	2.42 Billion	2.44 Billion
Long-Term Debt	1.33 Billion	2.22 Billion	2.19 Billion	2.19 Billion	2.2 Billion	2.2 Billion
Deferred Revenue Non Current	5.87 Million	6.11 Million	6.17 Million	6.17 Million	6.39 Million	6.26 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	24.35 Million	25.43 Million	29.22 Million	29.22 Million	28.35 Million	29.44 Million
Other Liabilities	-	1.00	-	-	-	-
Total Equity	2.94 Billion	2.03 Billion	2.04 Billion	2.04 Billion	2.08 Billion	2.09 Billion
Stock Holders Equity	2.94 Billion	2.03 Billion	2.04 Billion	2.04 Billion	2.08 Billion	2.09 Billion
Common Stock	1.66 Million	1.21 Million	1.21 Million	1.21 Million	2.01 Million	2.01 Million
Retained Earnings	-245.39 Million	-217.7 Million	-201.77 Million	-201.77 Million	-179.93 Million	-164.44 Million
Accumulated other comprehensive income	11.12 Million	15.62 Million	15.8 Million	15.8 Million	29.06 Million	30.99 Million
Common Stock Equity	2.94 Billion	2.03 Billion	2.04 Billion	2.04 Billion	2.08 Billion	2.09 Billion
Capital Lease Obligation	24.07 Million	25.15 Million	26.47 Million	26.47 Million	28.07 Million	29.39 Million
Total Investments	-	681 Thousand	-1000.00	1.18 Billion	4.72 Million	7.95 Million
Total Debt	1.37 Billion	2.27 Billion	2.24 Billion	2.24 Billion	2.25 Billion	2.25 Billion
Net Debt	1.29 Billion	2.2 Billion	2.2 Billion	2.2 Billion	2.2 Billion	2.15 Billion

Balance Sheet Charts

Astec LifeSciences Limited

ASTEC

Full Analysis

Annual Balance Sheets
Sasken Technologies Limited

SASKEN

Full Analysis

Annual Balance Sheets
Puuilo Oyj

PUUILO

Full Analysis

Annual Balance Sheets
FIPP S.A.

FIPP

Full Analysis

Annual Balance Sheets
BetterLife Pharma Inc.

BETR

Full Analysis

Annual Balance Sheets
Al-Modawat Specialized Medical Co.

9594

Full Analysis

Annual Balance Sheets

Global Stocks Search

Waystar Holding Corp. (WAY)

Annual Balance Sheets

Balance Sheet Charts

Astec LifeSciences Limited

Sasken Technologies Limited

Puuilo Oyj

FIPP S.A.

BetterLife Pharma Inc.

Al-Modawat Specialized Medical Co.